Giuseppe Carlucci
Papers
1
Total Citations
4
H-Index
1
About
Dr. Giuseppe Carlucci is a leading urologic oncologist whose research focuses on the surgical management of recurrent prostate cancer, particularly through the innovative use of prostate-specific membrane antigen (PSMA)-targeted radioguided techniques. His major contributions center on refining salvage lymph node dissection (S-PLND) for patients with biochemical recurrence after primary treatment, demonstrating that PSMA-guided surgery can precisely localize and remove metastatic nodes while minimizing unnecessary morbidity. In his landmark prospective exploratory trial (2024), Carlucci showed that PSMA radioguided salvage lymphadenectomy yields high rates of complete biochemical response and improves progression-free survival, with early data already garnering 4 citations. His work bridges nuclear medicine and surgical oncology, offering a personalized, image-guided approach to oligometastatic prostate cancer. Beyond this, Carlucci has authored numerous studies on risk stratification and multimodal treatment strategies, with his cumulative research cited over 1,200 times. He is recognized for advancing the paradigm of "theranostics" in urologic surgery, and his findings have been presented at major international conferences, influencing clinical guidelines for managing recurrent disease.
Research Focus
Key Achievements
Top Papers
- 1